We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
151
DELISTED
Veradigm Inc. Common Stock
MDRX
| $10.4M | 0.22% |
812,819
+419,742
| +107% | +$5.1M |
|
152
John Wiley & Sons Class A
WLY
$2.47B
| $9.97M | 0.21% |
188,923
+180,523
| +2,149% | +$9.44M |
|
|
WCC
153
WESCO International
WCC
$16.1B
| $9.8M | 0.21% |
171,000
-11,140
| -6% | -$692K |
|
154
Progressive
PGR
$120B
| $9.76M | 0.21% |
221,390
+84,390
| +62% | +$3.5M |
|
155
LPL Financial
LPLA
$25.9B
| $9.73M | 0.21% |
229,257
+222,837
| +3,471% | +$9.04M |
|
156
Insperity
NSP
$1.83B
| $9.6M | 0.21% |
270,470
+35,000
| +15% | +$1.42M |
|
157
Hilton Worldwide
HLT
$72.9B
| $9.53M | 0.2% |
+154,116
| New | +$9.59M |
|
158
KLA
KLAC
$286B
| $9.35M | 0.2% |
+1,021,290
| New | +$10.2M |
|
|
TCO
159
DELISTED
Taubman Centers Inc.
TCO
| $9.27M | 0.2% |
155,579
+76,339
| +96% | +$4.71M |
|
160
Primerica
PRI
$9.61B
| $9.15M | 0.2% |
+120,847
| New | +$9.48M |
|
161
SITE Centers
SITC
$224M
| $8.98M | 0.19% |
768,108
-3,767
| -0.5% | -$49.1K |
|
162
TD Synnex
SNX
$19.8B
| $8.91M | 0.19% |
148,554
-20,386
| -12% | -$1.14M |
|
163
State Street
STT
$50.6B
| $8.82M | 0.19% |
98,310
-20,080
| -17% | -$1.67M |
|
164
Silicon Laboratories
SLAB
$7.15B
| $8.75M | 0.19% |
128,058
+15,400
| +14% | +$1.11M |
|
165
ONE Gas
OGS
$5.02B
| $8.26M | 0.18% |
118,269
+11,670
| +11% | +$814K |
|
166
MarketAxess Holdings
MKTX
$4.06B
| $8.25M | 0.18% |
41,010
-21,640
| -35% | -$4.14M |
|
167
US Foods
USFD
$21B
| $8.16M | 0.17% |
299,646
-109,231
| -27% | -$3.11M |
|
168
CNO Financial Group
CNO
$4.91B
| $8.11M | 0.17% |
388,541
+270,140
| +228% | +$5.58M |
|
169
Manhattan Associates
MANH
$8.72B
| $8.11M | 0.17% |
168,795
-85,640
| -34% | -$4.06M |
|
170
Huntington Ingalls Industries
HII
$11.3B
| $7.93M | 0.17% |
42,621
-18,370
| -30% | -$3.59M |
|
171
Green Dot
GDOT
$743M
| $7.91M | 0.17% |
205,210
-640
| -0.3% | -$23.1K |
|
172
Biogen
BIIB
$29.6B
| $7.89M | 0.17% |
29,079
-22,388
| -43% | -$5.92M |
|
|
CXP
173
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $7.8M | 0.17% |
348,420
+58,300
| +20% | +$1.3M |
|
174
Norfolk Southern
NSC
$78.3B
| $7.67M | 0.16% |
+63,040
| New | +$7.41M |
|
|
MGLN
175
DELISTED
Magellan Health Services, Inc.
MGLN
| $7.64M | 0.16% |
104,826
-25,860
| -20% | -$1.82M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.